Immune checkpoint inhibitors-induced autoimmunity: The impact of gender
{{output}}
Objective: To evaluate prevalence and clinical features of immune-related adverse events (irAEs) to immune checkpoint inhibitors (ICIs) in accordance with the gender of treated cancer patients. ... ...
